Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial (2022)

First Author: Chandiwana N
Attributed to:  New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104322

PubMed Identifier: 36332361

Publication URI: http://europepmc.org/abstract/MED/36332361

Type: Journal Article/Review

Parent Publication: eBioMedicine

ISSN: 2352-3964